COMP <GO>
CLBT vs INTA // RETURN ON INVESTED CAPITAL (ROIC)
Cellebrite DI Ltd. (NASDAQ) VS. Intapp Inc. (NASDAQ) • 15-METRIC TALLY: CLBT 10
— INTA 0
▲ RETURN ON INVESTED CAPITAL (ROIC) LEADER: CLBT
LAST: $12.28 (+3.02%) • MKT CAP: $3.09B
roic
14.60%
LAST: $39.10 (-3.07%) • MKT CAP: $3.00B
roic
-9.90%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (CLBT VS. INTA)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | CLBT | INTA | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 84.20% | 74.00% | +10.20 | CLBT | /gross-margins <GO> |
| Return on Invested Capital (ROIC) ACTIVE | 14.60% | -9.90% | +24.50 | CLBT | /roic <GO> |
| EV/EBITDA & P/E Valuation | 38.1x | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | 5.19% | 4.07% | +1.12 | CLBT | /fcf-yield <GO> |
| Operating Margin | 14.00% | -5.40% | +19.40 | CLBT | /operating-margins <GO> |
| Net Profit Margin | 16.50% | -3.60% | +20.10 | CLBT | /net-margins <GO> |
| Revenue Growth (YoY) | 18.60% | 17.10% | +1.50 | CLBT | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 4.95 | 4.00 | +0.95 | CLBT | /balance-sheet <GO> |
| Piotroski F-Score Quality | 8/9 | 7/9 | +1.00 | CLBT | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 58.1 | 52.5 | +5.65 | CLBT | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | 33.1x | — | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $3.09B | $3.00B | $89.4M | CLBT | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | CLBT REV | INTA REV | CLBT GROSS % | INTA GROSS % | CLBT FCF | INTA FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $475.7M | $504.1M | 84.2% | 74.0% | $160.3M | $121.9M |
| FY 2024 | $401.2M | $430.5M | 84.4% | 71.3% | $123.6M | $64.8M |
| FY 2023 | $325.1M | $350.9M | — | — | $102.1M | $27.5M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
CLBT // BETA —
INTA // BETA —